FLT3 inhibitor design using molecular docking based virtual screening for acute myeloid leukemia

Acute Myeloid Leukaemia (AML) is a blood cancer, which affects the red blood cells in the bone marrow. Of the possible proteins that are affected in AML, fms-like tyrosine kinase 3 (FLT3) has long been recognized as a potential therapeutic target as it affects the other signaling pathways and leads...

Descripción completa

Detalles Bibliográficos
Autores principales: Gokhale, Padmini, Chauhan, Aashish Pratap Singh, Arora, Anushka, Khandekar, Natasha, Nayarisseri, Anuraj, Singh, Sanjeev Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677903/
https://www.ncbi.nlm.nih.gov/pubmed/31435156
http://dx.doi.org/10.6026/97320630015104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677903/
https://www.ncbi.nlm.nih.gov/pubmed/31435156
http://dx.doi.org/10.6026/97320630015104

Ejemplares similares